Teva

Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the…

Alvotech (NASDAQ: ALVO) og Teva Pharmaceuticals, bandarískt dótturfélag Teva Pharmaceutical Industries Ltd. (NYSE og TASE: TEVA) tilkynntu í dag um aukið samstarf á sviði þróunar, framleiðslu og markaðssetningar á líftæknilyfjahliðstæðum.…

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is considering the sale of its active pharmaceutical (API) ingredients production activities in a deal that could reach $2 billion, "Bloomberg" reports. The…

Back when Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) was recovering from its disastrous $40 billion acquisition of Allergan's Activis, the then new CEO Kare Schultz announced that the Israeli company…

What caused the share price of Teva Pharmaceutical Industries (NYSE: TEVA; TASE: TEVA) to fall almost 20% in April-May? A filing with the US Securities and Exchange Commission (SEC) last week provides a partial…

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today announced the conclusion of a full resolution on its US nationwide settlement agreement on opioid claims brought by US states, their subdivisions, and…

The Tel Aviv Stock Exchange fell today. The Tel Aviv 35 Index fell 0.60%, to 1,814.56 points; the Tel Aviv 125 Index fell 0.63%, to 1,812.53 points; and the BlueTech Global Index rose 0.41% to 354.30 points. The All Bond…

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today launched its new strategy with an emphasis on growth and innovation. The strategy called "Pivot to Growth" was unveiled at an investor conference at the…

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has reported its first quarter 2023 financial results today, missing on profit but beating the analysts on revenue. The Israeli company reported non-GAAP…

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) and MedinCell (Euronext: MEDCL) have announced that the US Food and Drug Administration (FDA) has approved UZEDY (risperidone) extended-release injectable…